{"rows":[{"id":5980,"title":"Caution before canonisation: a clinical and implementation science perspective on psychedelics","authors":"Andreas Paris, Foteïni Thoma, Aikaterini Velentza, Panagiota Pavlopoulou, Giorgos Metaxas","journal":"Frontiers in Psychiatry","publication_date":"2026-10-05","publication_year":2026,"doi":"10.3389/fpsyt.2026.1922928","pubmed_id":null,"openalex_id":"https://openalex.org/W7220367324","source_url":"https://doi.org/10.3389/fpsyt.2026.1922928","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,Spirituality,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-07 01:20:24","last_checked":"2026-10-09 01:20:19","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1922928","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2026.1922928","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3389/fpsyt.2026.1922928","source_url":"https://doi.org/10.3389/fpsyt.2026.1922928","doi":"10.3389/fpsyt.2026.1922928","pmid":"","publication_date":"2026-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5979,"title":"Psilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression.","authors":"Eun AC, Yang KH, Palamar JJ","journal":"Psychological medicine","publication_date":"2026-10-06","publication_year":2026,"doi":"10.1017/s0033291726106163","pubmed_id":"42834832","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-10-07 01:20:05","last_checked":"2026-10-09 01:20:05","bibtex":null,"source_record_id":"PMID:42834832","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42834832","source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","doi":"10.1017/s0033291726106163","pmid":"42834832","publication_date":"2026-10-06","importer_version":"2.1.3","text_redistributed":false}},{"id":5973,"title":"Serotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH.","authors":"Morena D, Lippi M, Biso L, Lucci F, Turillazzi E, Fineschi V, Scognamiglio P.","journal":"Clinical drug investigation","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1007/s40261-026-01599-z","pubmed_id":"42829418","openalex_id":"https://openalex.org/W7218417106","source_url":"https://doi.org/10.1007/s40261-026-01599-z","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Case Report,Safety,Toxicity,Drug Interactions","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-05 01:20:04","last_checked":"2026-10-09 01:20:19","bibtex":null,"source_record_id":"PMID:42829418","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s40261-026-01599-z","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42829418","source_url":"https://doi.org/10.1007/s40261-026-01599-z","doi":"10.1007/s40261-026-01599-z","pmid":"42829418","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5969,"title":"Open-label, Single-arm fMRI Study Evaluating the Effects of Psilocybin on Craving in Nicotine Dependence.","authors":"University of British Columbia","journal":"ClinicalTrials.gov","publication_date":"2026-10-01","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07852832","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Aging","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-10-02 01:26:31","last_checked":"2026-10-08 01:24:59","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07852832","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07852832","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07852832","source_url":"https://clinicaltrials.gov/study/NCT07852832","doi":"","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5963,"title":"Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial","authors":"Bukowski, H.; de Timary, P.; Belahda, D.; Igounenc, N.; Mura, T.; Serrand, C.; Luquiens, A.","journal":"medRxiv","publication_date":"2026-09-29","publication_year":2026,"doi":"10.64898/2026.09.26.26364086","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.26.26364086","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-30 01:20:46","last_checked":"2026-10-06 01:21:04","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.26.26364086","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.26.26364086","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.26.26364086","source_url":"https://doi.org/10.64898/2026.09.26.26364086","doi":"10.64898/2026.09.26.26364086","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5950,"title":"Exploring the Therapeutic Potential of Psilocybin: A Comprehensive Review of Clinical Trial Evidence and Implications for Rescheduling.","authors":"Abolhasani F, Rezaiezadeh H, Langarizadeh MA, Tavakoli MR, Ilaghi M, Zare P, Ravari FK, Alamdar F, Banazadeh M, Shabani M.","journal":"Mini reviews in medicinal chemistry","publication_date":"2026-09-18","publication_year":2026,"doi":"10.2174/0113895575443239260828094859","pubmed_id":"42770437","openalex_id":"https://openalex.org/W7213987315","source_url":"https://doi.org/10.2174/0113895575443239260828094859","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-23 01:20:07","last_checked":"2026-09-25 01:20:21","bibtex":null,"source_record_id":"PMID:42770437","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.2174/0113895575443239260828094859","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42770437","source_url":"https://doi.org/10.2174/0113895575443239260828094859","doi":"10.2174/0113895575443239260828094859","pmid":"42770437","publication_date":"2026-09-18","importer_version":"2.1.3","text_redistributed":false}},{"id":5928,"title":"Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.","authors":"Raffa RB.","journal":"Cureus","publication_date":"2026-09-13","publication_year":2026,"doi":"10.7759/cureus.116178","pubmed_id":"42733721","openalex_id":"https://openalex.org/W7212432134","source_url":"https://doi.org/10.7759/cureus.116178","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Review Article,Treatment-Resistant Depression,Drug Interactions,Genomics","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-15 01:20:05","last_checked":"2026-09-20 01:20:21","bibtex":null,"source_record_id":"PMID:42733721","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.7759/cureus.116178","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42733721","source_url":"https://doi.org/10.7759/cureus.116178","doi":"10.7759/cureus.116178","pmid":"42733721","publication_date":"2026-09-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5922,"title":"Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting System","authors":"Krantz MJ, Haigney MC, Southworth MR, Stockbridge N, Kao DP.","journal":"medRxiv","publication_date":"2026-09-10","publication_year":2026,"doi":"10.64898/2026.09.08.26362577","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.08.26362577","substance_tags":"psilocybin","topic_tags":"Addiction,Review Article,Safety,Adverse Events","study_type":"Review Article","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-12 01:20:56","last_checked":"2026-09-17 01:20:18","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.08.26362577","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.08.26362577","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.08.26362577","source_url":"https://doi.org/10.64898/2026.09.08.26362577","doi":"10.64898/2026.09.08.26362577","pmid":"","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5914,"title":"Craving Reduction and Smoking Outcomes in Psilocybin-Assisted and Standard Cessation Care.","authors":"Strandberg L, Fernandes TP, Shoshina II, Santos NA, Saether N.","journal":"Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999)","publication_date":"2026-09-09","publication_year":2026,"doi":"10.47626/1516-4446-2026-5060","pubmed_id":"42715291","openalex_id":null,"source_url":"https://doi.org/10.47626/1516-4446-2026-5060","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-10 01:20:06","last_checked":"2026-09-16 01:20:16","bibtex":null,"source_record_id":"PMID:42715291","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.47626/1516-4446-2026-5060","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42715291","source_url":"https://doi.org/10.47626/1516-4446-2026-5060","doi":"10.47626/1516-4446-2026-5060","pmid":"42715291","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}},{"id":5913,"title":"Who Is Reached by Supervised Psilocybin Services? Oregon Services Versus National Psilocybin Use","authors":"Costa GPA, Riggione C, Pittenger C, De Aquino JP.","journal":"medRxiv","publication_date":"2026-09-07","publication_year":2026,"doi":"10.64898/2026.09.03.26362170","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.03.26362170","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Wellbeing,Observational Study,Safety","study_type":"Observational Study","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-09 01:21:25","last_checked":"2026-09-14 01:20:16","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.03.26362170","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.03.26362170","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.03.26362170","source_url":"https://doi.org/10.64898/2026.09.03.26362170","doi":"10.64898/2026.09.03.26362170","pmid":"","publication_date":"2026-09-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5909,"title":"Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives.","authors":"Vásquez-Bonilla JN.","journal":"Human psychopharmacology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/hup.70063","pubmed_id":"42693701","openalex_id":"https://openalex.org/W7208787084","source_url":"https://doi.org/10.1002/hup.70063","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Review Article,Case Report,Animal Study,Safety,Drug Interactions,Inflammation,Immune Function","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-05 01:20:06","last_checked":"2026-09-08 01:20:16","bibtex":null,"source_record_id":"PMID:42693701","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1002/hup.70063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42693701","source_url":"https://doi.org/10.1002/hup.70063","doi":"10.1002/hup.70063","pmid":"42693701","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5905,"title":"Patterns of Psychedelic Use in Italy: Insights from the Global Psychedelic Survey","authors":"Beatrice Dal Bianco, Matteo Buonarroti, Alessandro Lo Jacono, Fabio Fesce, Alice Jelmoni, Lucia Cicchi, Andrea Anastasi, Eugenio Rossi, Mauro D'Alonzo, Alessandro Gelao, Caterina Bartoli, Omer Ahmed Syed, Christopher Nicholas, David Luke, Kyle Greenway, Sara Gloeckler, Sara de la Salle, Kobi Bernstein, Allison Feduccia, Alexandre Lehmann, Jacob S. Aday, Stephanie Lake, Daniel Kruger, Philippe Lucas","journal":"Clinical Neuropsychopharmacology and Addiction","publication_date":"2026-09-01","publication_year":2026,"doi":"10.53941/cna.2026.100012","pubmed_id":null,"openalex_id":"https://openalex.org/W7204922957","source_url":"https://doi.org/10.53941/cna.2026.100012","substance_tags":"psilocybin","topic_tags":"Addiction,Microdosing,Observational Study,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-03 01:20:15","last_checked":"2026-09-08 01:20:16","bibtex":null,"source_record_id":"DOI:10.53941/cna.2026.100012","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.53941/cna.2026.100012","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.53941/cna.2026.100012","source_url":"https://doi.org/10.53941/cna.2026.100012","doi":"10.53941/cna.2026.100012","pmid":"","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5902,"title":"Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders","authors":"Kathryn Fletcher, Jack Freestone, Nadine Ezard, Elizabeth Knock, Krista J. Siefried","journal":"Current Addiction Reports","publication_date":"2026-09-02","publication_year":2026,"doi":"10.1007/s40429-026-00783-7","pubmed_id":null,"openalex_id":"https://openalex.org/W7204988578","source_url":"https://doi.org/10.1007/s40429-026-00783-7","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Mechanism of Action,Emotional Processing,Mystical Experience,Randomized Controlled Trial,Review Article,Observational Study,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-03 01:20:15","last_checked":"2026-09-09 01:20:58","bibtex":null,"source_record_id":"DOI:10.1007/s40429-026-00783-7","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s40429-026-00783-7","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-026-00783-7","source_url":"https://doi.org/10.1007/s40429-026-00783-7","doi":"10.1007/s40429-026-00783-7","pmid":"","publication_date":"2026-09-02","importer_version":"2.1.3","text_redistributed":false}},{"id":5898,"title":"Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice.","authors":"Lovell TN, James PB, Hodgins SL, Johnson Noya S, Arner P, Bobadilla AC.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-08-30","publication_year":2026,"doi":"10.1177/02698811261478613","pubmed_id":"42670231","openalex_id":"https://openalex.org/W7204852149","source_url":"https://doi.org/10.1177/02698811261478613","substance_tags":"psilocybin,psilocin","topic_tags":"Anxiety,Addiction,Animal Study,Adverse Events","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-01 01:20:07","last_checked":"2026-09-06 01:20:16","bibtex":null,"source_record_id":"PMID:42670231","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261478613","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42670231","source_url":"https://doi.org/10.1177/02698811261478613","doi":"10.1177/02698811261478613","pmid":"42670231","publication_date":"2026-08-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5884,"title":"Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative Cases","authors":"Sarvi M, Lucas W, Levander X, Sarparast A.","journal":"Research Square","publication_date":"2026-08-26","publication_year":2026,"doi":"10.21203/rs.3.rs-10779254/v2","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10779254/v2","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Clinical Trial,Healthcare Workers,Safety","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"preprint","date_added":"2026-08-26 01:20:56","last_checked":"2026-09-02 01:20:31","bibtex":null,"source_record_id":"DOI:10.21203/rs.3.rs-10779254/v2","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.21203/rs.3.rs-10779254/v2","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-10779254/v2","source_url":"https://doi.org/10.21203/rs.3.rs-10779254/v2","doi":"10.21203/rs.3.rs-10779254/v2","pmid":"","publication_date":"2026-08-26","importer_version":"2.1.3","text_redistributed":false}},{"id":5877,"title":"The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review","authors":"Clark Rachel N","journal":"Lynchburg Journal of Medical Science","publication_date":"2026-08-20","publication_year":2026,"doi":"10.63932/3067-7106.1087","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.63932/3067-7106.1087","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-22 01:20:15","last_checked":"2026-08-24 01:20:13","bibtex":null,"source_record_id":"DOI:10.63932/3067-7106.1087","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.63932/3067-7106.1087","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.63932/3067-7106.1087","source_url":"https://doi.org/10.63932/3067-7106.1087","doi":"10.63932/3067-7106.1087","pmid":"","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}},{"id":5867,"title":"Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services","authors":"Korthuis P. Todd, Cook Ryan R., Gregoire Devin, Stauffer Christopher S., Luoma Jason B., Pertl Kellie, Des Jarlais Don, McCarty Dennis, Levander Ximena A., Hoffman Kim A., Wilson-Poe Adrianne R.","journal":"JAMA Network Open","publication_date":"2026-08-19","publication_year":2026,"doi":"10.1001/jamanetworkopen.2026.30608","pubmed_id":"42616497","openalex_id":"https://openalex.org/W7203781486","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Wellbeing,Observational Study,Veterans,Healthcare Workers,Safety","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-08-20 01:20:15","last_checked":"2026-08-26 01:20:59","bibtex":null,"source_record_id":"PMID:42616497","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42616497","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","doi":"10.1001/jamanetworkopen.2026.30608","pmid":"42616497","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5865,"title":"Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.","authors":"Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-08-17","publication_year":2026,"doi":"10.1177/02698811261473436","pubmed_id":"42609034","openalex_id":null,"source_url":"https://doi.org/10.1177/02698811261473436","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Systematic Review,Review Article,Safety,Drug Interactions","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-19 01:20:04","last_checked":"2026-08-24 01:20:14","bibtex":null,"source_record_id":"PMID:42609034","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261473436","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42609034","source_url":"https://doi.org/10.1177/02698811261473436","doi":"10.1177/02698811261473436","pmid":"42609034","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5863,"title":"Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy","authors":"Brian Ross","journal":"Journal of Psychedelic Studies","publication_date":"2026-08-13","publication_year":2026,"doi":"10.1556/2054.2026.00517","pubmed_id":null,"openalex_id":"https://openalex.org/W7202362192","source_url":"https://doi.org/10.1556/2054.2026.00517","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Review Article,Animal Study,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-15 01:20:13","last_checked":"2026-08-20 01:20:19","bibtex":null,"source_record_id":"DOI:10.1556/2054.2026.00517","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2026.00517","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00517","source_url":"https://doi.org/10.1556/2054.2026.00517","doi":"10.1556/2054.2026.00517","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5856,"title":"Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)","authors":"Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria","journal":"Journal of Clinical Medicine","publication_date":"2026-08-12","publication_year":2026,"doi":"10.3390/jcm15166228","pubmed_id":null,"openalex_id":"https://openalex.org/W7202254245","source_url":"https://doi.org/10.3390/jcm15166228","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-13 01:20:21","last_checked":"2026-08-19 01:20:25","bibtex":null,"source_record_id":"DOI:10.3390/jcm15166228","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/jcm15166228","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/jcm15166228","source_url":"https://doi.org/10.3390/jcm15166228","doi":"10.3390/jcm15166228","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}}],"total":842,"page":1,"per_page":20,"pages":43,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":"Addiction","study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}